Although the accuracy of quantitative real-time polymerase chain reaction (qRT-PCR) is highly dependent on the reliable reference genes, many commonly used reference genes are not stably expressed and as such are not suitable for quantification and normalization of qRT-PCR data. The aim of this study was to identify novel reliable reference genes in lung squamous-cell carcinoma. We used RNA sequencing (RNA-Seq) to survey the whole genome expression in 5 lung normal samples and 44 lung squamous-cell carcinoma samples. We evaluated the expression profiles of 15 commonly used reference genes and identified five additional candidate reference genes. To validate the RNA-Seq dataset, we used qRT-PCR to verify the expression levels of these 20 genes in a separate set of 100 pairs of normal lung tissue and lung squamous-cell carcinoma samples, and then analyzed these results using geNorm and NormFinder. With respect to 14 of the 15 common reference genes (B2M, GAPDH, GUSB, HMBS, HPRT1, IPO8, PGK1, POLR2A, PPIA, RPLP0, TBP, TFRC, UBC, and YWHAZ), the expression levels were either too low to be easily detected, or exhibited a high degree of variability either between lung normal and squamous-cell carcinoma samples, or even among samples of the same tissue type. In contrast, 1 of the 15 common reference genes (ACTB) and the 5 additional candidate reference genes (EEF1A1, FAU, RPS9, RPS11, and RPS14) were stably and constitutively expressed at high levels in all the samples tested. ACTB, EEF1A1, FAU, RPS9, RPS11, and RPS14 are ideal reference genes for qRT-PCR analysis of lung squamous-cell carcinoma, while 14 commonly used qRT-PCR reference genes are less appropriate in this context.
Introduction
Quantitative real-time polymerase chain reaction (qRT-PCR) is still the most common method to accurately quantify the mRNA transcription levels. qRT-PCR is fast, economical, and easy to use, and is especially suitable for the measurement of the expression of a limited number of genes. Given the highly quantitative nature of this technique, however, the use of a reliable normalization control is essential for meaningful comparison of the results between different samples. Accordingly, reference genes, usually housekeeping genes, are frequently used to normalize experimental deviation in the qRT-PCR datasets arising from differences in RNA quantity and quality, mRNA content, transcriptional activity, and operational deviation, among others. Since the accuracy of qRT-PCR is highly dependent on reliable reference genes, the expression levels of such genes should ideally be stably and constitutively elevated, and should not vary in different samples, nor be affected by experimental treatments. Since the expression patterns of many genes, including housekeeping genes, varies from tissue to tissue, proper validation of candidate reference genes is required prior to their use in qRT-PCR studies [1] [2] [3] . RNA sequencing (RNA-Seq) has in recent years emerged as a popular highthroughput technology for global gene expression analysis. In this technique, transcript levels are quantified in reads per kilobase of exon model per million mapped reads (RPKM), which reflects the molar concentration of a transcript normalized by the total read number in the measurement [4] . This normalization ideally avoids the experimental deviation in the qRT-PCR referred to above and facilitates transparent comparison of the expression levels of different genes between samples. As such, RNA-Seq is an ideal method to identify stably expressed reference genes across the entire genome.
Lung cancer is the most commonly diagnosed cancer worldwide, as well as the leading cause of cancer death [5] . Worldwide in 2008, it accounted for 13% (1.6 million) of the total cases and 18% (1.4 million) of the deaths [5] . Squamous-cell carcinoma is one of the major histological subtypes of lung cancer, and although a considerable number of qRT-PCR studies have focused on this subtype, they contain relatively few reliable reference genes. Although reference genes such as beta-actin (ACTB), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) are commonly used in this context, we found that the expression of certain reference genes in lung squamous-cell carcinoma is sufficiently variable to invalidate their use as internal controls. [6] [7] [8] [9] [10] . To solve this problem, here, we performed global gene expression profiling measurement in lung normal and squamous-cell carcinoma samples by using RNA-Seq, with the aim of identifying the most appropriate reference genes for the qRT-PCR analysis of lung squamouscell carcinoma.
Materials and Methods
Ethics statement This study was approved by Ethics Committee of Zhongshan Hospital, Fudan University (Approval No. 2011-219(2)) (Shanghai, China). All work conforms to the provisions of the Declaration of Helsinki. Written informed consent was obtained from all patients participating in this research at the time of hospitalization.
Tissue samples
Samples were obtained from patients with lung squamouscell carcinoma who underwent surgical resection between July 2012 and December 2012 at Zhongshan Hospital, Fudan University. Normal lung specimens were resected at least 3 cm away from tumor margin, while tumor samples were carefully removed from the center of squamous-cell carcinoma. All samples were quickly frozen in liquid nitrogen after removal and then stored at 2808C. A portion of each sample was paraffin embedded, HE stained, and then checked by an experienced pathologist to ensure that no cancer cell existed in the normal tissues, and that .80% cells in every tumor sample were squamous carcinoma cells. Finally, 5 normal tissue samples and 44 lung squamous-cell carcinoma tissues were obtained for use in the RNA-Seq analysis. One hundred additional pairs of normal tissue samples and lung squamous-cell carcinoma tissues were used for qRT-PCR validation.
RNA preparation
Total RNA was extracted from each sample with Trizol (Invitrogen, Carlsbad, USA), then re-dissolved in diethypyrocarbonate-treated water, quantified using NanoVue Plus spectrophotometry (GE Healthcare, Fairfield, USA), and integrity-evaluated using agarose gel electrophoresis. DNA contamination was eliminated using gDNA Eraser (TaKaRa, Tokyo, Japan) according to the manufacturer's guidelines. 
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Statistical analysis
The RPKM data from RNA-Seq were analyzed using IBM SPSS for windows, version 20 (Armonk, USA). The mean RPKM value was used to evaluate the expression level of a gene while the CV [coefficient of variance, equal to standard deviation (SD) divided by mean] of RPKM was used to assess the stability of their expression.
Two different statistical algorithms, geNorm and NormFinder, both of which provide a stability value for each gene in a pool of genes were applied to analyze the qRT-PCR data [11, 12] . The stability value was then used to validate the outcome of the RPKM data analysis.
Results
Expression profiles of commonly used reference genes in RNA-Seq data Our criteria for appropriate reference genes were: constitutively elevated expression for easy detection; and stable, comparable expression levels in both normal lung tissues and lung squamous-cell carcinomas. A total of 15 commonly used reference genes were evaluated against these criteria, namely: ACTB, beta-2-microglobulin (B2M), GAPDH, betaglucuronidase (GUSB), hydroxymethylbilane synthase (HMBS), hypoxanthine phosphoribosyltransferase 1 (HPRT1), importin
Reference genes in human lung SCC by RNA-Seq 8 (IPO8), phosphoglycerate kinase 1 (PGK1), polymerase RNA II DNA directed polypeptide A 220 kDa (POLR2A), peptidylprolyl isomerase A (PPIA), ribosomal protein large P0 (RPLP0), TATA box binding protein (TBP), transferrin receptor (TFRC), ubiquitin C (UBC), and tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta polypeptide (YWHAZ) (Fig. 1 and Table 1 ) [13] [14] [15] [16] [17] [18] [19] [20] [21] . The full name, NCBI Gene ID, function, and location of these genes can be found in Supplementary Table S1 .
As shown in Fig. 1 and Table 1 , several genes (GUSB, HMBS, HPRT1, IPO8, POLR2A, TBP, and TFRC) had very low RPKM values, and were expressed at such low levels that they would likely not be routinely detectable. Some common reference genes had widely varying expression levels between lung normal and squamous-cell carcinoma samples. These genes included B2M, GAPDH, HMBS, HPRT1, PGK1, POLR2A, PPIA, TBP, TFRC, UBC, and YWHAZ. GAPDH, for example, one of the most commonly used reference genes, had an average expression in lung squamous-cell carcinoma that was five folds more than that in normal lung tissues. And finally, the expression levels of several common reference genes (B2M, GAPDH, HMBS, HPRT1, PGK1, TFRC, and YWHAZ) varied considerably among samples in the same tissue type (normal or tumor). Of the 14 common reference genes tested, only ACTB met the criteria for elevated constitutive expression levels that were comparable between normal lung and squamous-cell carcinoma samples.
Identification of other candidate reference genes in RNA-Seq data Currently, there is no existing method available, so we took the following steps to identify genes with consistent expression between normal lung and squamous-cell carcinoma tissues.
First, the genes with a ,1 Mean(A) were excluded due to the possibility that RNA-Seq might be less robust at such low RPKM values [4] . Secondly, genes were excluded if Mean(N)/Mean(T) were ,0.8 or .1.2, or if their expression levels were significantly different between normal and squamous-cell carcinoma samples (P , 0.05). Of the initial .20,000 genes, 3276 genes which met the criteria above were drawn in a scatter plot, with CV(A) as the X-axis and Mean(A) as the Y-axis (Fig. 2) .
Here, Mean(A) denotes the mean of RPKM value of the gene in all samples. Mean(N) and Mean(T) denote the mean of RPKM value of the gene in lung normal samples and squamous-cell carcinoma samples, respectively. CV(A) denotes the CV of RPKM value of the gene in all the samples.
Finally, we selected six candidate reference genes from the top-left of Fig. 2 : ACTB, eukaryotic translation elongation factor 1 alpha 1 (EEF1A1), Finkel-Biskis-Reilly murine sarcoma virus ubiquitously expressed (FAU), ribosomal protein S9 (RPS9), ribosomal protein S11 (RPS11), and ribosomal protein S14 (RPS14). The expression profiles of these six genes were displayed in Fig. 3 and Table 2 . The full name, NCBI Gene ID, function, and location of these genes can also be found in Supplementary Table S1 . Our RNA-Seq data indicated that these six genes were consistently and robustly expressed, with the average RPKM values in excess of 1000, and the average CV values of no more than 0.3. These data indicated that these genes were the most highly and stably expressed genes in both lung normal and squamous-cell carcinoma samples. Interestingly, it is noteworthy that all six of these genes are considered 'housekeeping' genes [22] .
Validation of candidate reference genes by qRT-PCR Next, we used qRT-PCR to measure the expression levels of all 20 genes (the 15 common reference genes and the five novel candidate reference genes that we identified) in 100 Reference genes in human lung SCC by RNA-Seq pairs of normal lung and squamous-cell carcinoma samples. The primer sequences and melting temperature (T m ) used in our research and the product length, PCR efficiency, and correlation with dilution series (R 2 ) can be found in Supplementary Table S2 . qRT-PCR data were then analyzed by both geNorm and NormFinder to evaluate the stability of these genes [11, 12] .
As shown in Fig. 4 , the raw cycle threshold (CT) values of B2M, GAPDH, HMBS, HPRT1, PGK1, RPLP0, TFRC, and YWHAZ varied considerably between lung normal tissues and squamous-cell carcinoma samples, to an extent greater than that which could be explained by experimental errors. In contrast, the CT values of ACTB and the five novel candidate reference genes were sufficiently low to allow for routine detection. Moreover, the CT values of these six genes were comparable between normal lung and squamous-cell carcinoma tissues. Collectively, the results of qRT-PCR analysis were in broad agreement with those in the RNA-Seq dataset.
As shown in Table 3 , analysis of the raw CT data using geNorm and NormFinder, indicated that ACTB and the five novel candidate reference genes were stable with very high rank of stability values. Of these six genes, EEF1A1 was ranked by both analyses as the most stably expressed gene. In summary, the results of these analyses broadly validated the results of RNA-Seq analysis.
Discussion
In this study, we carried out RNA-Seq global expression profiling of normal lung and squamous-cell carcinoma to identify candidate reference genes for qRT-PCR. To our knowledge, this is the first description of the use of RNA-Seq to identify candidate reference genes for qRT-PCR. We found that ACTB, EEF1A1, FAU, RPS9, RPS11, and RPS14, were highly and stably expressed in both tissue types and, as such, are suitable reference genes for qRT-PCR-based studies of lung squamous-cell carcinoma. In contrast, 14 commonly used reference genes (B2M, GAPDH, GUSB, HMBS, HPRT1, IPO8, PGK1, POLR2A, PPIA, RPLP0, TBP, TFRC, UBC, and YWHAZ) failed to meet our selection criteria and should (N), (T), and (A) denote lung normal samples, squamous-cell carcinoma sample, and all samples, respectively. ACTB expressed highly and stably with high Mean(A), close to 1 Mean(N)/Mean(T), and low CV(A). Other 14 genes have either low Mean(A), Mean(N)/Mean(T) deviated to 1, or large CV(A) values, which means they were not highly and stably expressed in these samples. Figure 2 . The distribution of Mean(A) and CV(A) of genes in RNA-Seq data Genes with CV(A) . 1.0 were not displayed. These six genes at the frame at the top-left of the figure (ACTB, EEF1A1, FAU, RPS9, RPS11, and RPS14) were considered the most highly and stably expressed genes.
Reference genes in human lung SCC by RNA-Seq not be considered as suitable reference genes. We considered that our results were vitally important for those researchers investigating gene expression in lung squamous-cell carcinoma.
Another commonly used reference gene, 18S rRNA, its expression data were not included in the results of the RNA-Seq since it could not be enriched at the mRNA purification step. So whether or not 18S rRNA is suitable as endogenous control for qRT-PCR of lung squamous-cell carcinoma needs to be further verified.
Genes encoding ribosome proteins are universally conserved, and most of these genes were stably expressed in our samples. Three of our six successfully screened genes belong to this family, and many genes in this set have been verified in other studies to be suitable reference genes [23] [24] [25] . We also found that the expression levels of certain ribosome protein-encoding genes, such as ribosomal protein S7 (RPS7), ribosomal protein S10 (RPS10), RPLP0, and ribosomal protein L21 (RPL21) varied widely, ranging from single digits to tens of thousands of RPKM value. GAPDH, one of the most frequently used reference genes, has been widely used as a qRT-PCR reference gene in the expression analysis of lung squamous-cell carcinoma and other tumors [6,26 -28] . However, tumor cells show various metabolic anomalies, in which the best known are the typical high rate of glycolysis and lactate production termed 'Warburg effect' [29] . How tumor cells establish this altered metabolic phenotype is not entirely clear, but here our RNA-Seq results showed that the expression levels of many enzymes involving in glucose metabolism's expression elevated many folds, such as GAPDH, PGK1, hexokinase 2 (HK2), the M2 type of pyruvate kinase (PKM2), and lactate dehydrogenase (LDH), echoed lots of previous research [29] [30] [31] [32] [33] [34] [35] . So our results indicated that GAPDH is not entirely suitable as the reference gene of qRT-PCR in lung squamous-cell carcinoma or even other kinds of cancers. Moreover, the expression of GAPDH has been reported to be upregulated in many other disorders such as inflammation, diabetes, hypoxia, and some respiratory diseases, suggesting that it should only be cautiously used as a reference gene in studies of these diseases [36 -40] . Indeed, in a large-scale microarray metaanalysis, GAPDH was not recommended as a reference gene, except in heart or muscle [23] .
geNorm and NormFinder are two robust strategies to identify the most suitable reference gene from a given set of genes, and have been frequently used in reference genefinding analyses [11,12,17,41 -44] . geNorm calculates a Reference genes in human lung SCC by RNA-Seq gene's stability measured as the SD of the log2-transformed expression ratios of each gene compared with all others tested throughout the samples [12] . NormFinder uses a model-based approach to estimate expression stability based on intra-and inter-group variations for candidate genes [11] . In both the strategies, the stability value of one gene is largely determined by its correlation with other candidate genes, such that a low stability value will be obtained if the expression of the given gene is highly correlated with most other genes. And when most of the genes in the given set express stably in all sample, both methods will efficiently select the most stably expressed gene. In the event that most genes are not stably expressed, however, then neither geNorm nor NormFinder would be in a position to evaluate stability. This is a possible explanation of why certain genes such as PPIA, RPLP0, and TBP, which were not stable in the RNA-Seq and raw CT datasets, ranked high with these programs, while ACTB was ranked in the middle position. Moreover, it might also explain the differences between RNA-Seq and qRT-PCR in identifying the best reference genes in lung squamous-cell carcinoma [20, 21] . Based on this point, research based primarily on geNorm or NormFinder may need further verification.
Squamous-cell carcinoma and adenocarcinoma are the most two common histological subtypes of lung non-small-cell lung cancer. However, these two subtypes are quite different in host susceptibility, clonal evolution, molecular evolution, and molecular profiling [45] . Based on these caveats, in the absence of validation, reference genes which are suitable in lung squamous-cell carcinoma may not necessarily be directly applicable to other types of lung cancer.
Like RNA-Seq, microarray is capable of assaying genome-wide transcript expression levels in a single sample, and is frequently used in the screening of reference genes [23, 46, 47] . However, since microarray-based gene expression measurements are derived from nucleotide hybridization, which is prone to false signals arising from cross-hybridization, such data often require validation [48, 49] . Another inherent limitation of microarray is that they are highly reliant upon existing knowledge about genome sequence, such that newly discovered genes or gene variants are often not available on a given platform [50] . The expression of EEF1A1, FAU, RPS9, RPS11, and RPS14 were both highly and stably like ACTB. Reference genes in human lung SCC by RNA-Seq RNA-Seq has recently emerged as a complementary technique to microarray, bringing advantages such as low background noise, capable of detecting novel transcripts and alternative splicing forms, exon and nucleotide resolution, high dynamic range in detection, high precision, and high reproducibility [51] [52] [53] [54] .
In conclusion, ACTB, EEF1A1, FAU, RPS9, RPS11, and RPS14 are ideal reference genes in qRT-PCR research of lung squamous-cell carcinoma, while 14 commonly used reference genes, B2M, GAPDH, GUSB, HMBS, HPRT1, IPO8, PGK1, POLR2A, PPIA, RPLP0, TBP, TFRC, UBC, and YWHAZ, are less appropriate as reference genes in this context.
Supplementary Data
Supplementary data are available at ABBS online. ACTB, EEF1A1, FAU, RPS9, RPS11, and RPS14 were considered stable with very low stability values. EEF1A1 was ranked as the first most stable gene in both analyses.
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